Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6646
-0.0237 (-3.44%)
At close: Dec 5, 2025, 4:00 PM EST
0.6803
+0.0157 (2.36%)
After-hours: Dec 5, 2025, 7:44 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $79.94 million as of December 5, 2025. Its market cap has decreased by -15.48% in one year.
Market Cap
79.94M
Enterprise Value
45.60M
1-Year Change
-15.48%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $79.94M, a decrease of -67.19%. That is a compound annual growth rate of -15.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 79.94M | -11.25% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | 316.78M | 222.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |